Search

Your search keyword '"Hammerl, Peter"' showing total 139 results

Search Constraints

Start Over You searched for: Author "Hammerl, Peter" Remove constraint Author: "Hammerl, Peter"
139 results on '"Hammerl, Peter"'

Search Results

1. Disease trajectories in interstitial lung diseases – data from the EXCITING-ILD registry

2. Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry

3. Alles unter Kontrolle?

4. Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

5. Bronchoscopic Thermal Vapor Ablation (BTVA) in patients with severe upper lobe predominant emphysema: 36 months follow-up results from a prospective registry

6. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

9. Outcomes of patients with progressive fibrosing interstitial lung disease (PF-ILD) – data from a prospective ILD registry

10. Endobronchial Coil System versus Standard-of-Care Medical Management in the Treatment of Subjects with Severe Emphysema

11. European Journal of Immunology / IL31 transgenic mice show reduced allergeninduced lung inflammation

16. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia

17. IL‐31 transgenic mice show reduced allergen‐induced lung inflammation

18. Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity

19. The cytoskeletal regulator HEM1 governs B cell development and prevents autoimmunity

20. Late Breaking Abstract - Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF)

22. Treatment and survival diversities in different forms of ILD in Germany - EXCITING registry

23. Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity

24. Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study

25. CagA Phosphorylation in Helicobacter pylori-Infected B Cells Is Mediated by the Nonreceptor Tyrosine Kinases of the Src and Abl Families

26. Western Cross Blot

30. Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry

32. IL‐31 transgenic mice show reduced allergen‐induced lung inflammation.

35. Interims analysis of the EXCITING-ILD registry (registry for exploring clinical and epidemiological characteristics of interstitial lung diseases)

36. PLoS ONE / Immune reactions against gene gun vaccines are differentially modulated by distinct dendritic cell subsets in the skin

37. Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome

38. PLoS ONE / Structural integrity of the antigen is a determinant for the induction of T-helper type-1 immunity in mice by gene gun vaccines against E.coli Beta-Galactosidase

39. Immune Reactions against Gene Gun Vaccines Are Differentially Modulated by Distinct Dendritic Cell Subsets in the Skin

41. Western Cross Blot

44. Pulmonary hypertension due to chronic lung disease: Updated Recommendations of the Cologne Consensus Conference 2011

47. Epidermal Langerhans Cells Are Dispensable for Humoral and Cell-Mediated Immunity Elicited by Gene Gun Immunization

50. Detection of Serological Cross-Reactions by Western Cross-Blotting.

Catalog

Books, media, physical & digital resources